PPIDT00501
Drug Information
| Name | Nogapendekin alfa |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB18740 |
| Type | biotech |
| Indication | Nogapendekin alfa, in combination with [inbakicept] and Bacillus Calmette-Guérin (BCG), is indicated for the treatment of adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours.[L50592] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Solution | Intravesical |
400 ug/0.4mL
|